SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

“Gambling with our lives”: Anthropic researcher quits over race to superintelligence

A $50 million purchase has opened a new battle for Maccabi Tel Aviv

A $30 million loan is tearing apart Arieli’s controlling partnership

Altshuler Shaham shareholders consider sale of controlling stake

Buzz

Most popular

Daily

Weekly

1

What made Anthropic walk away from the $6 billion Decart deal?

2

Anthropic drops plans to acquire Israeli AI startup Decart

3

Palo Alto Networks founder Nir Zuk raises $245 million for new cybersecurity startup

4

Hapag-Lloyd and FIMI to submit improved bid for Zim

5

Israir sells $8 million of New York flights within hours of opening bookings

New Phase

3 stories about New Phase

ארליך ניו פייז - כדור ברזל נגד סרטן

The startup that wants to redefine stage four cancer

23.10.25|Hagai Gilboa, Maor Shalom Swisa

By heating tumors at the cellular level, New Phase hopes to transform treatment outcomes.

Groundbreaking Israeli cancer treatment gets FDA approval for clinical trials in U.S.

09.06.24|Ariela Karmel

New Phase CEO Ofer Shalev spoke to CTech about their technology which turns advanced cancer into a chronic ailment, extending the lifespans and treating symptoms without any of the side effects associated with other existing treatments

וידאו Ctech Mind the tech NY conference – Ofer Shalev

“We change cancer from a fatal disease to a chronic ailment”

Ofer Shalev, Founder & CEO at New Phase, spoke to CTech during Mind the Tech NY about New Phase and the technology behind the company